/Companies

CinCor Pharma

Cincinnati, US · Founded 2018 · Delaware corporation · 5 known investors

Find your way into CinCor Pharma

Sign up to see every warm intro you have to CinCor Pharma

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the CinCor Pharma team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Advancing clinical candidates for cardiovascular, metabolic and kidney diseases. (NASDAQ: CINC) (Acquired by AstraZeneca)

Founders & leadership

MDMarc de Garidel
Marc de GaridelExecutive

Investors · 5

Funding

SEC filings, press & company announcements

$142.9M disclosed across 1 of 2 rounds · 2019–2021

▶$142.9MraisedOct 2021 · 22 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Marc de GaridelExecutive Officer, Director
Offering amount
$142.9M
Amount sold
$142.9M
First sale
Sep 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does CinCor Pharma do?
Advancing clinical candidates for cardiovascular, metabolic and kidney diseases. (NASDAQ: CINC) (Acquired by AstraZeneca)
Who are CinCor Pharma's investors?
CinCor Pharma's investors include Sofinnova Partners, Sofinnova Ventures, 5AM Ventures, General Atlantic, Westlake Village BioPartners.
How much funding has CinCor Pharma raised?
CinCor Pharma has disclosed $142.9M raised across 1 of its 2 known rounds.
Where is CinCor Pharma headquartered?
CinCor Pharma is headquartered in Cincinnati, US.